Brian M Frier
Overview
Explore the profile of Brian M Frier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
3357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song S, Frier B
Diabet Med
. 2024 Nov;
42(3):e15466.
PMID: 39563613
Aims: To determine the prognosis associated with severe hypoglycaemia (SH) and diabetic ketoacidosis (DKA) in adults presenting to a hospital emergency department (ED). Methods: Medical records of adults with type...
2.
Garden G, Fan K, Paterson M, Shojaee-Moradie F, Borg Inguanez M, Manoli A, et al.
Diabetologia
. 2024 Nov;
68(1):52-68.
PMID: 39496965
Aims/hypothesis: Glycaemic control and clinical outcomes in diabetes are improved by continuous subcutaneous insulin infusion (CSII). Atmospheric pressure changes during flights may affect insulin delivery from pumps and cause unintended...
3.
Song S, Frier B
Lancet Diabetes Endocrinol
. 2024 Oct;
12(12):869-870.
PMID: 39461361
No abstract available.
4.
Cox D, Frier B, Bruggeman B, Durrani T, ElSayed N, Bannuru R, et al.
Diabetes Care
. 2024 Oct;
47(11):1889-1896.
PMID: 39432771
Many people with diabetes in the U.S. will seek or currently hold a license to drive. For many, a driver's license is essential for everyday life. Considerable discussion has focused...
5.
Landgraf W, Owens D, Frier B, Bolli G
Diabetes Ther
. 2024 Jun;
15(8):1769-1784.
PMID: 38879736
Introduction: This study aimed to evaluate glycemic outcomes in subphenotypes of type 2 diabetes (T2D) with HbA1c > 7.0%, previously on basal insulin (pre-BI) alone (≥ 42 U/day) or on...
6.
Landgraf W, Owens D, Frier B, Bolli G
Diabetes Obes Metab
. 2023 Oct;
26(2):503-511.
PMID: 37860918
Introduction: To compare responses to basal insulin glargine 300 U/ml (IGlar-300) and 100 U/ml (IGlar-100) in newly defined subphenotypes of type 2 diabetes. Methods: Insulin-naive participants (n = 858) from...
7.
8.
Garden G, Shojaee-Moradie F, Hutchison E, Frier B, Shaw K, Heller S, et al.
Diabetes Technol Ther
. 2023 Jun;
25(8):543-548.
PMID: 37384853
A preliminary study compared the use of continuous glucose monitoring (CGM) with the use of self-monitored blood glucose (SMBG) by aircraft pilots with insulin-treated diabetes in the United Kingdom, Ireland,...
9.
Song S, Frier B
Diabetes Obes Metab
. 2023 Jun;
25(10):2824-2834.
PMID: 37334521
Aims: To determine the clinical characteristics, risk factors and mortality outcomes associated with severe hypoglycaemia (SH) treated at a hospital emergency department. Materials And Methods: Adult patients presenting with SH...
10.
Landgraf W, Bigot G, Frier B, Bolli G, Owens D
Prim Care Diabetes
. 2023 May;
17(4):379-385.
PMID: 37142540
Aims: To assess insulin glargine 100 U/mL (IGlar-100) treatment outcomes according to newly-defined subgroups of type 2 diabetes mellitus (T2DM). Methods: Insulin-naïve T2DM participants (n = 2684) from nine randomised...